Category Archives:

By Duncan Miriri LUANDA (Reuters) -Angola got back $200 million of collateral in May that it had to post to JPMorgan earlier in the year, the finance ministry said, after the price of its bond rebound...

(Reuters) -Restaurant Brands beat second-quarter revenue estimates on Thursday, as its marketing efforts drove demand at Burger King and other brands in the U.S. and international markets. The company...

By Tom Polansek August 7 (Reuters) -Nebraska cattle rancher Craig Uden bought 200 extra mother cows and their babies over a few weeks in May to expand his herd as dry weather gave way to rain that rej...

(Reuters) -Global technology stocks advanced on Thursday in a relief rally after the latest tariff salvo from U.S. President Donald Trump largely exempted industry heavyweights from his threat to impo...

(Reuters) -U.S. President Donald Trump will sign an executive order on Thursday that aims to allow private equity, real estate, cryptocurrency and other alternative assets in 401(k)s, Bloomberg News r...

(Reuters) -Senators Ron Wyden and Elizabeth Warren are launching an investigation into UnitedHealth Group related to allegations that the healthcare conglomerate secretly paid nursing homes thousands ...

By Wen-Yee Lee TAIPEI (Reuters) -Taiwan authorities said on Thursday they were investigating 16 Chinese companies for allegedly poaching semiconductor and other high-tech talent, amid growing concerns...

(Reuters) -Shares of Airbnb slumped 6% before the bell on Thursday after the company forecast slower growth in the second half of the year, disappointing investors of the sector expecting a rebound in...

By Juveria Tabassum and Jessica DiNapoli August 7 (Reuters) -Lower-income U.S. households are cutting back on eating out, travel and pantry staples like diapers, soda and beer, as U.S. tariffs on impo...

By Patrick Wingrove and Maggie Fick NEW YORK (Reuters) -The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere in order to cut drug cos...